← Every company
Novartis AG SEC Filings
What Novartis AG has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
NVS overview →Filings on file
19
since Jan 25, 2017
Warning signs
0
none filed
Last results
—
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Feb 4, 2026 | Annual report 20-F | Read ↗ |
| Sep 29, 2025 | Tender offer SC TO-T | Read ↗ |
| May 27, 2025 | Tender offer SC TO-T | Read ↗ |
| Jan 31, 2025 | Annual report 20-F | Read ↗ |
| Jul 5, 2024 | Tender offer SC TO-T | Read ↗ |
| Apr 11, 2024 | Tender offer SC TO-T | Read ↗ |
| Jan 31, 2024 | Annual report 20-F | Read ↗ |
| May 15, 2023 | Annual report 20-F/A | Read ↗ |
| Feb 1, 2023 | Annual report 20-F | Read ↗ |
| Apr 26, 2022 | Annual report 20-F/A | Read ↗ |
| Feb 2, 2022 | Annual report 20-F | Read ↗ |
| Jan 26, 2021 | Annual report 20-F | Read ↗ |
| Jan 29, 2020 | Annual report 20-F | Read ↗ |
| Dec 5, 2019 | Tender offer SC TO-T | Read ↗ |
| Jan 30, 2019 | Annual report 20-F | Read ↗ |
| Apr 17, 2018 | Tender offer SC TO-T | Read ↗ |
| Jan 24, 2018 | Annual report 20-F | Read ↗ |
| Dec 7, 2017 | Tender offer SC TO-T | Read ↗ |
| Jan 25, 2017 | Annual report 20-F | Read ↗ |
Source: Novartis AG's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.